Last deal

$27M

Amount

Series A

Stage

01.02.2012

Date

3

all rounds

$77M

Total amount

General

About Company
Helicos BioSciences Corporation has developed technology for rapid analysis of genetic material in the life sciences industry.

Industry

Sector :

Subsector :

Also Known As

Newco LS6

founded date

01.01.2003

Operating Status

Closed

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company's True Single Molecule Sequencing (tSMS) technology directly sequences single molecules of DNA or RNA, while its Helicos Genetic Analysis Platform repetitively performs a cycle of biochemical reactions on individual DNA or RNA molecules and images the results after each cycle. The platform includes an instrument, an image analysis computer tower, associated reagents, and disposable supplies. Helicos recently launched a sequencing services program that allows access to its single molecule DNA, cDNA, and direct RNA sequencing technologies, which require no amplification, ligation, cDNA synthesis, or other complex sample manipulation and eliminate biases associated with amplification-based sequencing techniques. The company's mission is to improve productivity and affordability while continuing to discover new research and development findings.
Contacts